Yassmin A Elbanna

Type 1 Calreticulin Mutations Differentially Activate the IRE1α-XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms

R. Schneider, S. Oakes, S. Koschmieder, 2021, Blood.

Type 1 but not type 2 calreticulin mutations activate the IRE1a/XBP1 pathway of the unfolded protein response to drive myeloproliferative neoplasms.

R. Schneider, S. Oakes, S. Koschmieder, 2022, Blood cancer discovery.